Lupin Ltd reported an unanticipated quarterly loss after registering a one-time charge related to litigation over a blood pressure drug. Indian drugmaker created a provision...
Pharmaceutical major Lupin announced that the drug maker had received six observations from USFDA for its Unit 2 plant in Pithampur, Indore on 26 January....
According to the latest U.S. Food and Drug Administration’s (USFDA) Enforcement Report, Indian pharma major such as Lupin, Sun Pharma and Glenmark has decided to...